Editor-in-Chief: Jian Ge, MD, PhD
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
Prof. Ge’s research covers many aspects of ophthalmology and vision research, ranging from basic science to clinical fields. The followings have been involved: (1) Mechanism of experimental myopia in rhesus monkeys; (2) Gene screen and function in familial primary open angle glaucoma; (3) Stem cell and regeneration, iPS and tissue engineering in ophthalmology; (4) Wound healing and modulation of scar formation after glaucoma surgery; (5) New alternatives in the treatment of glaucoma, special interest in Phaco, Shunt, Laser therapy.
Currently, Prof. Ge is Member of standing committee of the Asia Pacific Glaucoma Society, Honorary Chairman of the Chinese Ophthalmologic Society, Vice chairman of the Chinese Eye Doctor Association, Former Chairman of the Chinese Glaucoma Society, Honorary Lifetime Director of State Key Laboratory of Ophthalmology, Chairman of Guangdong Eye Doctor Association, Member of standing committee of the Evidence-based medicine committee of the Chinese doctor association, Editor-in-chief of Eye Science and Molecular Vision, Vice editor-in-chief of Chinese Journal of Ophthalmology and Chinese Journal of Experimental Ophthalmology.
Prof. Ge has ever got big government funding, including The National Basic Research Program of China (973 Program) for the pathogenesis and management for irreversible blindness eye diseases; the Key project of national natural science funding for the stem cell and tissue engineering therapy for the irreversible blindness.
Editor-in-Chief: Yizhi Liu, MD, PhD
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
Dr. Yizhi Liu is Professor and President of Zhongshan Ophthalmic Center, Chief of National 973 Programs. Dr. Liu is the Standing Committee of Asia-Pacific Academy of Ophthalmology Congress (APAO), Vice Chairman of Chinese Ophthalmological Society, Vice Leader of Cataract and Artificial Lens Group, Chinese Ophthalmological Society, Vice Chairman of Guangdong Medical Association, Chairman of Guangdong Ophthalmological Society. Dr. Liu also serves as co-Editor-in-Chief of the journal Molecular Vision, and Deputy Editor-in-Chief of Current Molecular Medicine.
Having been working in medical treatment, education, research of ophthalmology and blindness prevention for more than 30 years, he is one of the experts who carried out and promoted minimally invasive cataract surgeries in China. Currently, Dr. Liu is participating in several key research projects supported by National Key Research Plan, Key Program of National Natural Science Fund and Key International Cooperation Program of National Natural Science Fund etc.. He has authored more than 60 papers published in journals like NEJM, Nature, Science, BMJ, PNAS etc.. Dr. Liu received Arthur Lim Award of APAO in 2014.